Clinical Trial Update: Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

View source ↗

Summary

A completed clinical trial comparing gemcitabine therapy to the FOLFIRINOX regimen for locally advanced or metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Gemcitabine (Gemcitabine)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer | Status: COMPLETED